Literature DB >> 33491972

Outpatient Opioid Prescriptions are Associated with Future Substance use Disorders and Overdose Following Adolescent Trauma.

Teresa M Bell1, Jodi L Raymond, Alejandro C Mongalo, Zachary W Adams, Thomas M Rouse, LeRanna Hatcher, Katie Russell, Aaron E Carroll.   

Abstract

OBJECTIVE: This study aims to determine if outpatient opioid prescriptions are associated with future substance use disorder (SUD) diagnoses and overdose in injured adolescents five years following hospital discharge. SUMMARY BACKGROUND DATA: Approximately, 1 in 8 adolescents are diagnosed with an SUD and 1 in 10 experience an overdose in the five years following injury. State laws have become more restrictive on opioid prescribing by acute care providers for treating pain, however, prescriptions from other outpatient providers are still often obtained.
METHODS: This was a retrospective cohort study of patients ages 12-18 admitted to two level I trauma centers. Demographic and clinical data contained in trauma registries were linked to a regional database containing five years of electronic health records and prescription data. Regression models assessed whether number of outpatient opioid prescription fills after discharge at different time points in recovery were associated with a new SUD diagnosis or overdose, while controlling for demographic and injury characteristics, as well as depression and PTSD diagnoses.
RESULTS: We linked 669 patients (90.9%) from trauma registries to a regional health information exchange database. Each prescription opioid refill in the first 3 months after discharge increased the likelihood of new SUD diagnoses by 55% (OR:1.55, CI:1.04-2.32). Odds of overdose increased with ongoing opioid use over 2-4 years post-discharge (p = 0.016-0.025).
CONCLUSIONS: Short-term outpatient opioid prescribing over the first few months of recovery had the largest effect on developing an SUD, while long-term prescription use over multiple years was associated with a future overdose.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33491972      PMCID: PMC8815331          DOI: 10.1097/SLA.0000000000004769

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   13.787


  38 in total

Review 1.  The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.

Authors:  Roger Chou; Judith A Turner; Emily B Devine; Ryan N Hansen; Sean D Sullivan; Ian Blazina; Tracy Dana; Christina Bougatsos; Richard A Deyo
Journal:  Ann Intern Med       Date:  2015-02-17       Impact factor: 25.391

2.  A Systematic Review of the Relative Frequency and Risk Factors for Prolonged Opioid Prescription Following Surgery and Trauma Among Adults.

Authors:  M Gabrielle Pagé; Irina Kudrina; Hervé Tchala Vignon Zomahoun; Jordie Croteau; Daniela Ziegler; Patrice Ngangue; Elisabeth Martin; Maude Fortier; Esthelle Ewusi Boisvert; Pierre Beaulieu; Céline Charbonneau; Jennifer Cogan; Raoul Daoust; Marc O Martel; Andrée Néron; Philippe Richebé; Hance Clarke
Journal:  Ann Surg       Date:  2020-05       Impact factor: 12.969

3.  Trajectory subtypes after injury and patient-centered outcomes.

Authors:  Ben L Zarzaur; Teresa Bell
Journal:  J Surg Res       Date:  2015-12-30       Impact factor: 2.192

4.  Screening and treating hospitalized trauma survivors for posttraumatic stress disorder and depression.

Authors:  Terri A deRoon-Cassini; Joshua C Hunt; Timothy J Geier; Ann Marie Warren; Kenneth J Ruggiero; Kamela Scott; Jessica George; Meredith Halling; Gregory Jurkovich; Samir M Fakhry; Douglas Zatzick; Karen J Brasel
Journal:  J Trauma Acute Care Surg       Date:  2019-08       Impact factor: 3.313

5.  Association of Mental Health Conditions and Treatments With Long-term Opioid Analgesic Receipt Among Adolescents.

Authors:  Patrick D Quinn; Kwan Hur; Zheng Chang; Eric L Scott; Erin E Krebs; Matthew J Bair; Martin E Rickert; Robert D Gibbons; Kurt Kroenke; Brian M D'Onofrio
Journal:  JAMA Pediatr       Date:  2018-05-01       Impact factor: 16.193

6.  Altered Signaling in the Descending Pain-modulatory System after Short-Term Infusion of the μ-Opioid Agonist Remifentanil.

Authors:  Christian Sprenger; Iris-Carola Eichler; Lars Eichler; Christian Zöllner; Christian Büchel
Journal:  J Neurosci       Date:  2018-02-12       Impact factor: 6.167

7.  Association between posttraumatic stress and depressive symptoms and functional outcomes in adolescents followed up longitudinally after injury hospitalization.

Authors:  Douglas F Zatzick; Gregory J Jurkovich; Ming-Yu Fan; David Grossman; Joan Russo; Wayne Katon; Frederick P Rivara
Journal:  Arch Pediatr Adolesc Med       Date:  2008-07

8.  Extramedical use of prescription pain relievers by youth aged 12 to 21 years in the United States: national estimates by age and by year.

Authors:  Elizabeth A Meier; Jonathan P Troost; James C Anthony
Journal:  Arch Pediatr Adolesc Med       Date:  2012-09-01

9.  Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults.

Authors:  Anh P Nguyen; Jason M Glanz; Komal J Narwaney; Ingrid A Binswanger
Journal:  JAMA Netw Open       Date:  2020-03-02

10.  Epidemiological evidence on extra-medical use of prescription pain relievers: transitions from newly incident use to dependence among 12-21 year olds in the United States using meta-analysis, 2002-13.

Authors:  Maria A Parker; James C Anthony
Journal:  PeerJ       Date:  2015-10-20       Impact factor: 2.984

View more
  1 in total

1.  Variability in opioid pain medication prescribing for adolescent trauma patients in a sample of US pediatric trauma centers.

Authors:  Michael J Mello; Janette Baird; Julie R Bromberg; Anthony Spirito; Mark R Zonfrillo; Lois K Lee; Emily R Christison-Lagay; Stephanie M Ruest; Charles W Pruitt; Karla A Lawson; Andrew W Kiragu; Isam Nasr; Jeremy T Aidlen; Beth E Ebel; R Todd Maxson; Kelli Scott; Sara J Becker
Journal:  Trauma Surg Acute Care Open       Date:  2022-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.